Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

被引：0
|
作者：
Rivera-Caravaca, J. M. [1 ]
Esteve-Pastor, M. A. [1 ]
Vicente, V. [2 ]
Valdes, M. [1 ]
Lip, G. Y. [3 ]
Marin, F. [1 ]
Roldan-Schilling, V. [2 ]
机构：
[1] Hosp Univ Virgen de la Arrixaca, Murcia, Spain
[2] Univ Murcia, Hosp Univ Morales Meseguer, Murcia, Spain
[3] Birmingham City Hosp, Birmingham, W Midlands, England
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6442
引用
收藏
页码：1347 / 1348
页数：2
相关论文
共 50 条
  • [1] Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients
    Rivera-Caravaca, Jose Miguel
    Roldan, Vanessa
    Asuncion Esteve-Pastor, Maria
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    Marin, Francisco
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (07) : 1448 - 1454
  • [2] Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
    Gallego, Pilar
    Roldan, Vanessa
    Marin, Francisco
    Romera, Marta
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) : 1189 - 1198
  • [3] Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor The Loire Valley Atrial Fibrillation Project
    Fauchier, Laurent
    Lecoq, Coralie
    Clementy, Nicolas
    Bernard, Anne
    Angoulvant, Denis
    Ivanes, Fabrice
    Babuty, Dominique
    Lip, Gregory Y. H.
    CHEST, 2016, 149 (04) : 960 - 968
  • [4] Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation
    Carlisle, Matthew A.
    Shrader, Peter
    Fudim, Marat
    Pieper, Karen S.
    Blanco, Rosalia G.
    Fonarow, Gregg C.
    Naccarelli, Gerald V.
    Gersh, Bernard J.
    Reiffel, James A.
    Kowey, Peter R.
    Steinberg, Benjamin A.
    Freeman, James V.
    Ezekowitz, Michael D.
    Singer, Daniel E.
    Allen, Larry A.
    Chan, Paul S.
    Pokorney, Sean D.
    Peterson, Eric D.
    Piccini, Jonathan P.
    HEART RHYTHM O2, 2022, 3 (06): : 621 - 628
  • [5] Stopping oral anticoagulation and the risk of thrombotic events and mortality in patients with atrial fibrillation
    Gallego, P.
    Marin, F.
    Romera, M.
    Valdes, M.
    Vicente, V.
    Lip, G. Y. H.
    Roldan, V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 257 - 258
  • [6] Oral anticoagulation and stroke in atrial fibrillation
    Epstein, EF
    Natarajan, I
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24): : 2360 - 2361
  • [7] Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
    Garcia Rodriguez, Luis Alberto
    Cea Soriano, Lucia
    Munk Hald, Stine
    Hallas, Jesper
    Balabanova, Yanina
    Brobert, Gunnar
    Vora, Pareen
    Sharma, Mike
    Gaist, David
    HEART, 2021, 107 (07) : 542 - 548
  • [8] Oral anticoagulation in atrial fibrillation Balancing the risk of stroke with the risk of bleed
    Kosar, Lynette
    Jin, Margaret
    Kamrul, Rejina
    Schuster, Brenda
    CANADIAN FAMILY PHYSICIAN, 2012, 58 (08) : 850 - 858
  • [9] Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation
    Hylek, EM
    Go, AS
    Chang, YC
    Jensvold, NG
    Henault, LE
    Selby, JV
    Singer, DE
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11): : 1019 - 1026
  • [10] Anemia is an independently risk factor for bleeding in atrial fibrillation patients on oral anticoagulation
    Roldan, V.
    Fernandez, H.
    Gallego, P.
    Orenes-Pinero, E.
    Montoro-Garcia, S.
    Cerezo, J. J.
    Valdes, M.
    Vicente, V.
    Lip, G. Y.
    Marin, F.
    EUROPEAN HEART JOURNAL, 2012, 33 : 509 - 509
12345